David G. Livermore

569 total citations
17 papers, 362 citations indexed

About

David G. Livermore is a scholar working on Molecular Biology, Social Psychology and Spectroscopy. According to data from OpenAlex, David G. Livermore has authored 17 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Social Psychology and 4 papers in Spectroscopy. Recurrent topics in David G. Livermore's work include Neuroendocrine regulation and behavior (6 papers), Organic and Inorganic Chemical Reactions (4 papers) and Biochemical and Molecular Research (3 papers). David G. Livermore is often cited by papers focused on Neuroendocrine regulation and behavior (6 papers), Organic and Inorganic Chemical Reactions (4 papers) and Biochemical and Molecular Research (3 papers). David G. Livermore collaborates with scholars based in United Kingdom, United States and Germany. David G. Livermore's co-authors include Michael Allen, Paul G. Wyatt, Fabrizio Nerozzi, P.M. Woollard, Anne M. Exall, Alan D. Borthwick, M.J. Perren, Shilina Roman, Wendy R. Irving and Richard J. D. Hatley and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and British Journal of Pharmacology.

In The Last Decade

David G. Livermore

17 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Livermore United Kingdom 11 170 167 56 55 41 17 362
Natasha M. Kablaoui United States 14 191 1.1× 643 3.9× 34 0.6× 17 0.3× 24 0.6× 20 828
Rupa Ray United States 9 257 1.5× 57 0.3× 36 0.6× 8 0.1× 12 0.3× 10 474
J. Custot France 6 103 0.6× 49 0.3× 13 0.2× 22 0.4× 29 0.7× 6 363
Roeland C. Vollinga Netherlands 12 337 2.0× 274 1.6× 8 0.1× 36 0.7× 27 0.7× 16 631
Joseph Pawluczyk United States 11 133 0.8× 285 1.7× 113 2.0× 3 0.1× 59 1.4× 21 490
Michel Maillard United States 12 366 2.2× 191 1.1× 8 0.1× 368 6.7× 48 1.2× 16 698
Dae Hong Shin South Korea 11 273 1.6× 214 1.3× 4 0.1× 258 4.7× 16 0.4× 16 512
Paul Hershberger United States 13 237 1.4× 101 0.6× 4 0.1× 15 0.3× 21 0.5× 20 397
Shunji Ichikawa Japan 8 168 1.0× 182 1.1× 6 0.1× 164 3.0× 6 0.1× 8 356
Niall M. Hamilton United Kingdom 13 240 1.4× 143 0.9× 19 0.3× 13 0.2× 2 0.0× 30 467

Countries citing papers authored by David G. Livermore

Since Specialization
Citations

This map shows the geographic impact of David G. Livermore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Livermore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Livermore more than expected).

Fields of papers citing papers by David G. Livermore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Livermore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Livermore. The network helps show where David G. Livermore may publish in the future.

Co-authorship network of co-authors of David G. Livermore

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Livermore. A scholar is included among the top collaborators of David G. Livermore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Livermore. David G. Livermore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bürli, Roland W., David G. Livermore, Robert G. Newman, et al.. (2024). Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 100. 129629–129629. 7 indexed citations
2.
Ahmed, Saleh A., Andrew Ayscough, Richard Davenport, et al.. (2017). 1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction. Journal of Medicinal Chemistry. 60(13). 5663–5672. 28 indexed citations
3.
Stevens, Alexander J., Anton D. Michel, Daryl S. Walter, et al.. (2010). Synthesis and structure–activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor. Bioorganic & Medicinal Chemistry Letters. 20(10). 3161–3164. 21 indexed citations
4.
Healy, Mark P., Gianpaolo Bravi, Andrew Billinton, et al.. (2010). Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 20(15). 4683–4688. 12 indexed citations
5.
Gleave, Robert J., Paul Beswick, Andrew J. Brown, et al.. (2009). 2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 19(23). 6578–6581. 9 indexed citations
6.
Michel, A.D., William C. Clay, Shilina Roman, et al.. (2008). Identification of regions of the P2X7receptor that contribute to human and rat species differences in antagonist effects. British Journal of Pharmacology. 155(5). 738–751. 45 indexed citations
7.
Hall, Adrian, Susan H. Brown, A. R. Chowdhury, et al.. (2007). Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(16). 4450–4455. 16 indexed citations
8.
Allen, Michael, David G. Livermore, & J.E. Mordaunt. (2006). 7 Oxytocin Antagonists as Potential Therapeutic Agents for the Treatment of Preterm Labour. Progress in medicinal chemistry. 44. 331–373. 7 indexed citations
9.
Borthwick, Alan D., Anne M. Exall, Richard J. D. Hatley, et al.. (2006). 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo Potency. Journal of Medicinal Chemistry. 49(14). 4159–4170. 34 indexed citations
10.
Wyatt, Paul G., Michael Allen, Alan D. Borthwick, et al.. (2005). 2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR. Bioorganic & Medicinal Chemistry Letters. 15(10). 2579–2582. 50 indexed citations
11.
Borthwick, Alan D., Anne M. Exall, David G. Livermore, et al.. (2005). 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 2. Synthesis, Chirality, and Pharmacokinetics. Journal of Medicinal Chemistry. 48(22). 6956–6969. 39 indexed citations
12.
Wyatt, Paul G., Michael Allen, C. Gardner, et al.. (2002). Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives. Bioorganic & Medicinal Chemistry Letters. 12(10). 1405–1411. 36 indexed citations
13.
Wyatt, Paul G., Michael Allen, Alison J. Foster, et al.. (2002). Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives. Bioorganic & Medicinal Chemistry Letters. 12(10). 1399–1404. 27 indexed citations
14.
Mahmoudian, Mahmoud, Brian A.M. Rudd, Brian J. Cox, et al.. (1998). A versatile procedure for the generation of nucleoside 5′-carboxylic acids using nucleoside oxidase. Tetrahedron. 54(28). 8171–8182. 10 indexed citations
15.
Giblin, Gerard M.P., et al.. (1994). Synthesis of novel monocyclic squalestatin analogues as potential inhibitors of squalene synthase. Bioorganic & Medicinal Chemistry Letters. 4(18). 2155–2160. 5 indexed citations
16.
KINSMAN, O. S., David G. Livermore, & Candice A. Smith. (1993). Antifungal properties in a novel series of triazino[5,6-b]indoles. Antimicrobial Agents and Chemotherapy. 37(6). 1243–1246. 15 indexed citations
17.
Livermore, David G. & David A. Widdowson. (1982). Cobaloximes. Part 2. A modified Schrauzer synthesis for base-sensitive cobaloximes. Journal of the Chemical Society Perkin Transactions 1. 1019–1019. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natasha M. Kablaoui Breakdown of academic impact, for papers by Rupa Ray Breakdown of academic impact, for papers by J. Custot Breakdown of academic impact, for papers by Roeland C. Vollinga Breakdown of academic impact, for papers by Joseph Pawluczyk Breakdown of academic impact, for papers by Michel Maillard Breakdown of academic impact, for papers by Dae Hong Shin Breakdown of academic impact, for papers by Paul Hershberger Breakdown of academic impact, for papers by Shunji Ichikawa Breakdown of academic impact, for papers by Niall M. Hamilton
Rankless by CCL
2026